CN110981816A - 一种4-氨基-2.6-二甲氧基嘧啶的合成方法 - Google Patents
一种4-氨基-2.6-二甲氧基嘧啶的合成方法 Download PDFInfo
- Publication number
- CN110981816A CN110981816A CN201911379297.6A CN201911379297A CN110981816A CN 110981816 A CN110981816 A CN 110981816A CN 201911379297 A CN201911379297 A CN 201911379297A CN 110981816 A CN110981816 A CN 110981816A
- Authority
- CN
- China
- Prior art keywords
- amino
- reaction
- chloropyrimidine
- formic acid
- dimethoxypyrimidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LNTJJKHTAZFVJJ-UHFFFAOYSA-N 2,6-dimethoxypyrimidin-4-amine Chemical compound COC1=CC(N)=NC(OC)=N1 LNTJJKHTAZFVJJ-UHFFFAOYSA-N 0.000 title claims abstract description 47
- 238000001308 synthesis method Methods 0.000 title abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- DBPKMSBWOKAKLA-UHFFFAOYSA-N 4-chloropyrimidine Chemical compound ClC1=CC=NC=N1 DBPKMSBWOKAKLA-UHFFFAOYSA-N 0.000 claims abstract description 23
- HVTORSQIIBJSON-UHFFFAOYSA-N 4-amino-6-chloropyrimidine-5-carboxylic acid Chemical compound NC1=NC=NC(Cl)=C1C(O)=O HVTORSQIIBJSON-UHFFFAOYSA-N 0.000 claims abstract description 21
- ZJEFILYXLZSVJZ-UHFFFAOYSA-N 4-chloropyrimidine-5-carboxylic acid Chemical compound OC(=O)C1=CN=CN=C1Cl ZJEFILYXLZSVJZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- KGBLYFGHJNGQBK-UHFFFAOYSA-N 4,6-dichloropyrimidine-5-carboxylic acid Chemical compound OC(=O)C1=C(Cl)N=CN=C1Cl KGBLYFGHJNGQBK-UHFFFAOYSA-N 0.000 claims abstract description 11
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000011114 ammonium hydroxide Nutrition 0.000 claims abstract description 10
- 238000006198 methoxylation reaction Methods 0.000 claims abstract description 10
- 238000005660 chlorination reaction Methods 0.000 claims abstract description 8
- 238000005915 ammonolysis reaction Methods 0.000 claims abstract description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 6
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 239000012320 chlorinating reagent Substances 0.000 claims abstract description 4
- 239000002253 acid Substances 0.000 claims abstract description 3
- 230000000911 decarboxylating effect Effects 0.000 claims abstract description 3
- 238000006114 decarboxylation reaction Methods 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 88
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 230000002194 synthesizing effect Effects 0.000 claims description 20
- 238000010992 reflux Methods 0.000 claims description 14
- 230000035484 reaction time Effects 0.000 claims description 11
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 8
- SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- XJPZKYIHCLDXST-UHFFFAOYSA-N 4,6-dichloropyrimidine Chemical compound ClC1=CC(Cl)=NC=N1 XJPZKYIHCLDXST-UHFFFAOYSA-N 0.000 claims description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- GRONZTPUWOOUFQ-UHFFFAOYSA-M sodium;methanol;hydroxide Chemical compound [OH-].[Na+].OC GRONZTPUWOOUFQ-UHFFFAOYSA-M 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 229910052698 phosphorus Inorganic materials 0.000 abstract description 3
- 239000011574 phosphorus Substances 0.000 abstract description 3
- 239000002351 wastewater Substances 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- 239000000047 product Substances 0.000 description 33
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 21
- 239000000460 chlorine Substances 0.000 description 21
- 229910052801 chlorine Inorganic materials 0.000 description 21
- 238000001914 filtration Methods 0.000 description 21
- 238000001816 cooling Methods 0.000 description 18
- 238000010438 heat treatment Methods 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 238000001035 drying Methods 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- UPVBKNZVOJNQKE-UHFFFAOYSA-N 2,6-dichloropyrimidin-4-amine Chemical compound NC1=CC(Cl)=NC(Cl)=N1 UPVBKNZVOJNQKE-UHFFFAOYSA-N 0.000 description 11
- 229910052799 carbon Inorganic materials 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 239000012295 chemical reaction liquid Substances 0.000 description 8
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 8
- CGVYSSVYQHRZMD-UHFFFAOYSA-N 4-amino-2,6-dichloropyrimidine-5-carboxylic acid Chemical compound NC1=NC(Cl)=NC(Cl)=C1C(O)=O CGVYSSVYQHRZMD-UHFFFAOYSA-N 0.000 description 7
- 239000003513 alkali Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000004537 pulping Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 238000007789 sealing Methods 0.000 description 4
- 238000010183 spectrum analysis Methods 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- -1 amino hydrogen Chemical class 0.000 description 3
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- GIKMWFAAEIACRF-UHFFFAOYSA-N 2,4,5-trichloropyrimidine Chemical compound ClC1=NC=C(Cl)C(Cl)=N1 GIKMWFAAEIACRF-UHFFFAOYSA-N 0.000 description 2
- OIZBUZPDLCPLSX-UHFFFAOYSA-N 2,6-dichloro-1h-pyrimidin-2-amine Chemical compound NC1(Cl)NC(Cl)=CC=N1 OIZBUZPDLCPLSX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- KEVRHVMWBKFGLO-UHFFFAOYSA-N 2,4-dimethoxypyrimidine Chemical compound COC1=CC=NC(OC)=N1 KEVRHVMWBKFGLO-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 description 1
- 229960000973 sulfadimethoxine Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911379297.6A CN110981816B (zh) | 2019-12-27 | 2019-12-27 | 一种4-氨基-2.6-二甲氧基嘧啶的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911379297.6A CN110981816B (zh) | 2019-12-27 | 2019-12-27 | 一种4-氨基-2.6-二甲氧基嘧啶的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110981816A true CN110981816A (zh) | 2020-04-10 |
CN110981816B CN110981816B (zh) | 2022-07-05 |
Family
ID=70078029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911379297.6A Active CN110981816B (zh) | 2019-12-27 | 2019-12-27 | 一种4-氨基-2.6-二甲氧基嘧啶的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110981816B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112645894A (zh) * | 2020-11-30 | 2021-04-13 | 江苏中旗科技股份有限公司 | 制备砜吡草唑中间体5,5-二甲基-4,5-二氢异恶唑-3-硫代甲脒盐酸盐的方法 |
CN114014815A (zh) * | 2021-12-06 | 2022-02-08 | 浙江科技学院 | 一种对环境友好的4-氨基-2,6-二甲氧基嘧啶制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014068171A1 (en) * | 2012-11-05 | 2014-05-08 | Medeia Therapeutics Ltd | N-substituted 4-aminophenols and corresponding quinone imines |
CN104761505A (zh) * | 2015-03-06 | 2015-07-08 | 江苏天和制药有限公司 | 氯嘧啶类化合物的一种制备方法 |
-
2019
- 2019-12-27 CN CN201911379297.6A patent/CN110981816B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014068171A1 (en) * | 2012-11-05 | 2014-05-08 | Medeia Therapeutics Ltd | N-substituted 4-aminophenols and corresponding quinone imines |
CN104761505A (zh) * | 2015-03-06 | 2015-07-08 | 江苏天和制药有限公司 | 氯嘧啶类化合物的一种制备方法 |
Non-Patent Citations (3)
Title |
---|
HAN WANG,等: "Large-Scale Solvent-Free Chlorination of Hydroxy-Pyrimidines,-Pyridines, -Pyrazines and -Amides Using Equimolar POCl3", 《MOLECULES》 * |
THOMAS J.DELIA,等: "2,4,6-trichloropyrimidine. Reaction with sodium amide", 《J.HETEROCYCLIC CHEM.》 * |
杨珍珍,等: "2,6-二甲氧基-4-氨基嘧啶及其金属(Cu,Co)配合物的合成与表征", 《合成化学》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112645894A (zh) * | 2020-11-30 | 2021-04-13 | 江苏中旗科技股份有限公司 | 制备砜吡草唑中间体5,5-二甲基-4,5-二氢异恶唑-3-硫代甲脒盐酸盐的方法 |
CN112645894B (zh) * | 2020-11-30 | 2022-04-15 | 江苏中旗科技股份有限公司 | 制备砜吡草唑中间体5,5-二甲基-4,5-二氢异恶唑-3-硫代甲脒盐酸盐的方法 |
CN114014815A (zh) * | 2021-12-06 | 2022-02-08 | 浙江科技学院 | 一种对环境友好的4-氨基-2,6-二甲氧基嘧啶制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110981816B (zh) | 2022-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110981816B (zh) | 一种4-氨基-2.6-二甲氧基嘧啶的合成方法 | |
CN108033922B (zh) | 一种3-酰基喹喔啉酮衍生物的制备方法 | |
EP2872492B1 (en) | Process for the preparation of rilpivirine using a novel intermediate | |
CN105254575B (zh) | 一种磺胺嘧啶的合成方法 | |
CN107089984B (zh) | 一种替卡格雷的合成方法 | |
CN108373468B (zh) | 一种n-2-吡啶-5-嘧啶甲胺的制备方法 | |
CN103772278A (zh) | 一种重要四氢异喹啉衍生物中间体及其合成方法 | |
CN109020938A (zh) | 一种杨梅素的制备方法 | |
CN111039876A (zh) | 一种4-氨基-2,6-二甲氧基嘧啶的制备方法 | |
Curd et al. | 71. Synthetic antimalarials. Part IV. 2-Phenylguanidino-4-aminoalkylamino-6-methylpyrimidines | |
CN109438307A (zh) | 一种l-硒代蛋氨酸的制备方法 | |
CN108484508A (zh) | 一种5-三氟甲基尿嘧啶的合成方法 | |
CN104761524A (zh) | 一种化合物及其在制备抗寄生虫病药物中的应用 | |
CN109232441B (zh) | 一种4-氨基-2,6-二甲氧基嘧啶的制备方法 | |
FI57400C (fi) | Foerfarande foer framstaellning av 2,4-diamino-5-bensylpyrimidiner | |
US3900476A (en) | 2(2'-pyrimidylamino)quinazolines and their preparation | |
CN105348285A (zh) | 一种低成本高收率制备腺嘌呤的方法 | |
CN111454217A (zh) | 阿普替尼中间体的制备方法 | |
CN106916148B (zh) | 一种合成依匹哌唑的方法 | |
CN111377927A (zh) | 一种硫代或硒代酰胺类化合物及其制备方法 | |
CN114014815B (zh) | 一种对环境友好的4-氨基-2,6-二甲氧基嘧啶制备方法 | |
CN111303045A (zh) | 2-乙氧基-4,6-二氟嘧啶的生产工艺 | |
CN105777714B (zh) | 氟马替尼的精制方法 | |
CN111333651B (zh) | 一种含SCF3或SeCF3的杂环化合物及其制备方法 | |
US20160168161A1 (en) | Method for producing heterocyclic compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 225200 No.86 Shuangshu Road, Xiannv Town, Jiangdu District, Yangzhou City, Jiangsu Province Applicant after: Tianhe Pharmaceutical Co.,Ltd. Address before: 225200 No.86 Shuangshu Road, Xiannv Town, Jiangdu District, Yangzhou City, Jiangsu Province Applicant before: YANGZHOU TIANHE PHARMACEUTICAL Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 225200 No.86 Shuangshu Road, Xiannv Town, Jiangdu District, Yangzhou City, Jiangsu Province Patentee after: Tianhe Pharmaceutical Co.,Ltd. Country or region after: China Address before: 225200 No.86 Shuangshu Road, Xiannv Town, Jiangdu District, Yangzhou City, Jiangsu Province Patentee before: Tianhe Pharmaceutical Co.,Ltd. Country or region before: China |